Literature DB >> 11473114

Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA)n repeat element within an Alu sequence.

K N Hogeveen1, M Talikka, G L Hammond.   

Abstract

Sex hormone-binding globulin (SHBG) is the major sex steroid-binding protein in human plasma and is produced by the liver. Plasma SHBG levels vary considerably between individuals and are influenced by hormonal, metabolic, and nutritional factors. We have now found that a (TAAAA)(n) pentanucleotide repeat, located within an alu sequence at the 5' boundary of the human SHBG promoter, influences its transcriptional activity in association with downstream elements, including an SP1-binding site. Furthermore, SHBG alleles within the general population contain at least 6-10 TAAAA repeats, and the transcriptional activity of a human SHBG promoter-luciferase reporter construct containing 6 TAAAA repeats was significantly lower than for similar reporter constructs containing 7-10 TAAAA repeats when tested in human HepG2 hepatoblastoma cells. This difference in transcriptional activity reflected the preferential binding of a 46-kDa liver-enriched nuclear factor to an oligonucleotide containing 6 rather than 7-10 TAAAA repeats. Thus, a (TAAAA)(n) element within the human SHBG promoter influences transcriptional activity in HepG2 cells and may contribute to differences in plasma SHBG levels between individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473114     DOI: 10.1074/jbc.M104681200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  The biological effects of simple tandem repeats: lessons from the repeat expansion diseases.

Authors:  Karen Usdin
Journal:  Genome Res       Date:  2008-07       Impact factor: 9.043

Review 2.  Diverse roles for sex hormone-binding globulin in reproduction.

Authors:  Geoffrey L Hammond
Journal:  Biol Reprod       Date:  2011-05-25       Impact factor: 4.285

Review 3.  Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

Review 4.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

Review 5.  Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.

Authors:  C Chen; J Smothers; A Lange; J E Nestler; J F Strauss Iii; E P Wickham Iii
Journal:  Minerva Endocrinol       Date:  2010-12       Impact factor: 2.184

6.  Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk.

Authors:  Brian L Yaspan; Joan P Breyer; Qiuyin Cai; Qi Dai; J Bradford Elmore; Isaac Amundson; Kevin M Bradley; Xiao-Ou Shu; Yu-Tang Gao; William D Dupont; Wei Zheng; Jeffrey R Smith
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

7.  Genetics of polycystic ovary syndrome.

Authors:  N Prapas; A Karkanaki; I Prapas; I Kalogiannidis; I Katsikis; D Panidis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 8.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

9.  The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism.

Authors:  Leandros A Lazaros; Elissavet G Hatzi; Christina E Pamporaki; Prodromos I Sakaloglou; Nectaria V Xita; Sophia I Markoula; Theodoros I Stefos; Konstantinos A Zikopoulos; Ioannis A Georgiou
Journal:  J Assist Reprod Genet       Date:  2012-08-23       Impact factor: 3.412

10.  ATM and ATR protect the genome against two different types of tandem repeat instability in Fragile X premutation mice.

Authors:  Ali Entezam; Karen Usdin
Journal:  Nucleic Acids Res       Date:  2009-08-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.